Navigation Links
Non-coding RNAs help silence the mammalian transcription

Dr. Shirley Tilghman and colleagues (Princeton University) lend new insight into the mechanism of genomic imprinting, demonstrating a necessary role for a non-coding RNA transcript in the silencing of an imprinted gene cluster in mice.

Imprinting, or the differential expression of a gene based upon which parent it has been inherited from, is integral to normal growth and development. Two human disorders, Prader-Willi and Angelman syndromes, result from the deletion of the identical portion of chromosome 15. Imprinting determines which disorder arises: When the deletion involves the chromosome 15 that came from the father, the child has Prader-Willi syndrome, but when the deletion involves the chromosome 15 that came from the mother, the child has Angelman syndrome.

In the mouse, a cluster of nine genes on the distal end of the number 7 chromosome is imprinted. Dr. Tilghman and colleagues made a series of targeted alterations to ascertain which sequences are responsible for their paternal-specific silencing. The researchers show that this imprinted gene silencing requires the elongation of a paternally-expressed non-coding RNA transcript, Kcnq1ot1.

"As we explore the mechanism of genomic imprinting in greater detail, it is becoming clear that there is not a single explanation for the silencing of all imprinted genes. Rather mammals have co-opted multiple transcriptional regulatory mechanisms that were already evolved. In the case of the Kcnqt1ot1, the mechanism utilizes some form of RNA silencing. The variation in silencing mechanisms lends further support to the argument that imprinting arose gradually over a long period in mammals, not all at once," explains Dr. Tilghman.


'"/>

Source:Cold Spring Harbor Laboratory


Page: 1

Related biology news :

1. Used in a new way, RNA interference permanently silences key breast cancer gene
2. Restoring silenced suppressor gene kills lung-cancer cells
3. Tool developed to silence genes in specific tissues using RNAi
4. Interfering RNA silences genes in slippery immune cells
5. Researchers find protein that silences genes
6. MIT: Pulsing light silences overactive neurons
7. Insulator helps silence genes in dormant herpes virus
8. MicroRNAs have shaped the evolution of the majority of mammalian genes
9. Marsupial genome reveals insights into mammalian evolution
10. Sexual reproduction delays aging in a mammalian species
11. First major study of mammalian disorderly proteins
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. Hays ... DNA as a Field Application Specialist. , “I am thrilled that Dr. Young ... DNA. “In further expanding our capacity as a scientific integrator, Hays brings a wealth ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
(Date:6/23/2016)... 2016 Andrew D ... http://doi.org/10.17925/OHR.2016.12.01.22 Published recently in ... from touchONCOLOGY, Andrew D Zelenetz , discusses ... care is placing an increasing burden on healthcare ... therapies. With the patents on many biologics expiring, ...
Breaking Biology Technology: